Skip to content

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

Home
Pharma applications
Non-pharma applications
CD derivatives
Events
E-ducation

Tag: nanozyme

March 27, 2020 Events

10th Global Nanotechnology Congress and Expo

10th Global Nanotechnology Congress and Expo will be organized in Frankfurt, Germany during November 23-24, 2020. The main theme of congress

Continue reading

September 12, 2019 CD derivatives / Non-pharma applications / Uncategorized

Cyclodextrin-based nanozymes

Nanozymes are nanomaterials with enzyme-like properties. These artificial enzymes have emerged more robust than the natural enzymes and find applications

Continue reading

Search for:

Recent Posts

FDA Approves Veklury® (Remdesivir) for the Treatment of Non-Hospitalized Patients at High Risk for COVID-19 Disease Progression
Time- and frequency-dependent changes in acoustic startle reflex amplitude following cyclodextrin-induced outer and inner cell loss
Cyclodextrins-in-Liposomes: A Promising Delivery System for Essential Oils
Insulin Complexation with Cyclodextrins—A Molecular Modeling Approach
International Forum on Biopolymers and Polymer Science

Tags

antiviral Biotechnology Cancer therapy Captisol Cholesterol Clinical trial conference coronavirus Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems FDA Food Gilead History HPBCD Nanoparticles nanotechnology Niemann Pick Disease RAMEB remdesivir SBECD Special issue Sugammadex Synthesis Trappsol wastewater treatment

Follow Us

LinkedIn
Twitter
Facebook

Categories

Agriculture (13)
Analysis (21)
CD as API (162)
CD derivatives (207)
Cosmetics and toilettry (14)
Drug delivery (303)
E-ducation (47)
Environmental (54)
Events (133)
Food (79)
Gene delivery (6)
In Hungarian (4)
Life sciences (3)
Non-pharma applications (130)
Other industrial use (46)
Pharma applications (524)
Supramolecular systems (14)
Uncategorized (32)

Top Posts

FDA Approves Veklury® (Remdesivir) for the Treatment of Non-Hospitalized Patients at High Risk for COVID-19 Disease Progression
Time- and frequency-dependent changes in acoustic startle reflex amplitude following cyclodextrin-induced outer and inner cell loss
Virtual Public Meeting: Endpoint Considerations to Facilitate Drug Development for Niemann-Pick Type C (NPC)
Cyclodextrins-in-Liposomes: A Promising Delivery System for Essential Oils
Contribution of Franz Schardinger to cyclodextrins
HPBCD is a unique component in Janssen's COVID-19 vaccine candidate
Insulin Complexation with Cyclodextrins—A Molecular Modeling Approach
CD-related project received award for the best coordination
GRAS status of CD derivatives
Cyclodextrin dimers to treat atherosclerotic plaques by targeting various forms of cholesterol

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 380 other subscribers

Email Address

Loading Comments...

Write a Comment...

Email (Required)

Name (Required)

Website